Welcome to LookChem.com Sign In|Join Free
  • or
1-(2-chloroacetyl)-3-M-tolylurea, also known as Tolfenamic acid, is a chemical compound belonging to the class of urea derivatives. It is characterized by an acylurea structure with a chloroacetyl substituent at the 1-position and a 3-methylphenyl substituent at the 3-position of the urea ring. 1-(2-chloroacetyl)-3-M-tolylurea is known for its ability to inhibit the synthesis of prostaglandins, which are responsible for causing inflammation and pain.

5544-33-2

Post Buying Request

5544-33-2 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

5544-33-2 Usage

Uses

Used in Pharmaceutical Industry:
1-(2-chloroacetyl)-3-M-tolylurea is used as a non-steroidal anti-inflammatory drug (NSAID) for the treatment of pain, inflammation, and fever. Its application is based on its ability to inhibit prostaglandin synthesis, thereby reducing inflammation and pain associated with various conditions.
Used in Pain Management:
1-(2-chloroacetyl)-3-M-tolylurea is used as an analgesic for the treatment of mild to moderate pain. Its effectiveness in pain management is attributed to its inhibition of prostaglandin synthesis, which is a key factor in the perception of pain.
Used in Treatment of Inflammatory Conditions:
1-(2-chloroacetyl)-3-M-tolylurea is used as an anti-inflammatory agent for the treatment of various inflammatory conditions, such as migraine headaches, dysmenorrhea, and rheumatoid arthritis. Its anti-inflammatory properties help alleviate the symptoms and reduce the severity of these conditions.
Used in Fever Reduction:
1-(2-chloroacetyl)-3-M-tolylurea is used as an antipyretic to reduce fever. By inhibiting prostaglandin synthesis, it helps lower body temperature and provide relief from feverish symptoms.

Check Digit Verification of cas no

The CAS Registry Mumber 5544-33-2 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 5,5,4 and 4 respectively; the second part has 2 digits, 3 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 5544-33:
(6*5)+(5*5)+(4*4)+(3*4)+(2*3)+(1*3)=92
92 % 10 = 2
So 5544-33-2 is a valid CAS Registry Number.

5544-33-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 14, 2017

Revision Date: Aug 14, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-chloro-N-[(3-methylphenyl)carbamoyl]acetamide

1.2 Other means of identification

Product number -
Other names 1-chloroacetyl-3-m-tolyl-urea

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:5544-33-2 SDS

5544-33-2Relevant academic research and scientific papers

Design, Synthesis, and Antitumor Activity Evaluation of Trifluoromethyl-Substituted Pyrimidine Derivatives Containing Urea Moiety

Chao, Gao,Heyi, Yan,Honglin, Dai,Hongmin, Liu,Jiaxin, Zheng,Lihong, Shan,Limin, Liu,Luye, Zhang,Na, Li,Qiurong, Zhang,Tao, Wang,Xiujuan, Liu,Yang, Zhang,Zhengjie, Wang

, p. 1301 - 1311 (2021/12/23)

Abstract: In order to find efficient new antitumor drugs, a series of novel pyrimidine derivatives containing urea moiety were designed and synthesized, and the antitumor activity of four human tumor cells was evaluated by MTT analysis. The results showed that most of the target compounds exhibited moderate antitumor activity. In particular, the IC50 (concentration required to achieve 50% inhibition of the tumor cell proliferation) value of compound 2-((4-(4-ethylphenoxy)-6-(trifluoromethyl)pyrimidin-2-yl)thio)-N-((4-ethylphenyl)carba-moyl)acetamide for MGC-803 (human gastric carcinoma cell line) was 2.51 ± 0.17 μmol L–1, the anti-proliferative activity was significantly better than the positive control drug 5-fluorouracil. Molecular docking revealed that this compound can bind well to the active site of epidermal growth factor receptor (EGFR), and it may become a potential antitumor drug.

Synthesis and biological evaluation of novel L-homoserine lactone analogs as quorum sensing inhibitors of pseudomonas aeruginosa

Liu, Haoyue,Gong, Qianhong,Luo, Chunying,Liang, Yongxi,Kong, Xiaoyan,Wu, Chunli,Feng, Pengxia,Wang, Qing,Zhang, Hui,Wireko

, p. 1088 - 1098 (2019/10/02)

In this study, we synthesized four series of novel L-homoserine lactone analogs and evaluated their in vitro quorum sensing (QS) inhibitory activity against two biomonitor strains, Chromobacterium violaceum CV026 and Pseudomonas aeruginosa PAO1. Studies of the structure–activity relationships of the set of L-homoserine lactone analogs indicated that phenylurea-containing N-dithiocarbamated homoserine lactones are more potent than (Z)-4-bromo-5-(bromomethylene)-2(5H)-furanone (C30), a positive control for biofilm formation. In particular, compared with C30, QS inhibitor 11f significantly reduced the production of virulence factors (pyocyanin, elastase and rhamnolipid), swarming motility, the formation of biofilm and the mRNA level of QS-related genes regulated by the QS system of PAO1. These results reveal 11f as a potential lead compound for developing novel antibacterial quorum sensing inhibitors.

Quinoxaline-based inhibitors of Ebola and Marburg VP40 egress

Loughran, H. Marie,Han, Ziying,Wrobel, Jay E.,Decker, Sarah E.,Ruthel, Gordon,Freedman, Bruce D.,Harty, Ronald N.,Reitz, Allen B.

supporting information, p. 3429 - 3435 (2016/07/21)

We prepared a series of quinoxalin-2-mercapto-acetyl-urea analogs and evaluated them for their ability to inhibit viral egress in our Marburg and Ebola VP40 VLP budding assays in HEK293T cells. We also evaluated selected compounds in our bimolecular complementation assay (BiMC) to detect and visualize a Marburg mVP40–Nedd4 interaction in live mammalian cells. Antiviral activity was assessed for selected compounds using a live recombinant vesicular stomatitis virus (VSV) (M40 virus) that expresses the EBOV VP40 PPxY L-domain. Finally selected compounds were evaluated in several ADME assays to have an early assessment of their drug properties. Our compounds had low nM potency in these assays (e.g., compounds 21, 24, 26, 39), and had good human liver microsome stability, as well as little or no inhibition of P450 3A4.

Alkylation potency and protein specificity of aromatic urea derivatives and bioisosteres as potential irreversible antagonists of the colchicine-binding site

Fortin, Jessica S.,Lacroix, Jacques,Desjardins, Michel,Patenaude, Alexandre,Petitclerc, Eric,C.-Gaudreault, Rene

, p. 4456 - 4469 (2008/03/13)

A number of N-phenyl-N′-(2-chloroethyl)ureas (CEUs) have been shown to be potent antimitotics through their covalent binding to the colchicine-binding site on intracellular β-tubulin. The present communication aimed to evaluate the role of the electrophilic 2-chloroethyl amino moiety of CEU on cell growth inhibition and the specificity of the drugs as irreversible antagonists of the colchicine-binding site. To that end, several N-phenyl-N′-(2-ethyl)urea (EU), N-phenyl-N′-(2-chloroethyl)urea (CEU), N-aryl amino-2-oxazoline (OXA), and N-phenyl-N′-(2-chloroacetyl)urea (CAU) derivatives were prepared and tested for their antiproliferative activity, their effect on the cell cycle, and their irreversible binding to β-tubulin. EU derivatives were devoid of antiproliferative activity. CEUs (2h-2i, 2k, 2l, OXA 3e, 3h, 3i, 3k, 3l, tBCEU, and ICEU), OXA (3h, 3i, 3k, 3l, tBOXA, and IOXA), and CAU (4a-4m, tBCAU, and ICAU) had GI50 between 1.7 and 10 μM on three tumor cell lines. Cytotoxic CEU and OXA arrested the cell cycle in G2/M phase, while the corresponding CAU were not phase specific. Finally, Western blot analysis clearly showed that only CEUs 2h, 2k, 2l, tBCEU, ICEU and OXA 3h, 3i, 3k, 3l, tBOXA,and IOXA were able to bind irreversibly to the colchicine-binding site. Our results suggest that increasing the potency of the electrophilic moiety of the aromatic ureas enhances their antiproliferative activity but decreases significantly their capacity to covalently bind to the colchicine-binding site.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 5544-33-2